Kendall Capital Management Sells 235 Shares of Cardinal Health, Inc. (NYSE:CAH)

Kendall Capital Management decreased its position in Cardinal Health, Inc. (NYSE:CAH) by 9.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,330 shares of the company’s stock after selling 235 shares during the quarter. Kendall Capital Management’s holdings in Cardinal Health were worth $276,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. State Street Corp raised its holdings in Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after purchasing an additional 627,253 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after acquiring an additional 42,082 shares in the last quarter. Pacer Advisors Inc. increased its holdings in shares of Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after acquiring an additional 191,568 shares in the last quarter. Amundi increased its holdings in shares of Cardinal Health by 5.5% during the fourth quarter. Amundi now owns 2,116,291 shares of the company’s stock valued at $259,309,000 after acquiring an additional 110,605 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Cardinal Health by 3.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company’s stock valued at $179,653,000 after acquiring an additional 44,386 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $126.40 on Monday. The stock has a market capitalization of $30.53 billion, a price-to-earnings ratio of 23.58, a PEG ratio of 1.49 and a beta of 0.66. The stock’s 50-day simple moving average is $125.58 and its two-hundred day simple moving average is $118.88. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.60%. Cardinal Health’s payout ratio is currently 37.69%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on CAH shares. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a report on Tuesday, January 7th. Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and raised their price target for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Citigroup raised their price target on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a report on Friday, January 10th. JPMorgan Chase & Co. raised their price target on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Finally, TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.